166 related articles for article (PubMed ID: 26197392)
1. Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin-arginine.
Lenz E; Jensen KT; Blaabjerg LI; Knop K; Grohganz H; Löbmann K; Rades T; Kleinebudde P
Eur J Pharm Biopharm; 2015 Oct; 96():44-52. PubMed ID: 26197392
[TBL] [Abstract][Full Text] [Related]
2. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin-omeprazole as therapeutic hybrids? Salt and co-amorphous systems enhancing physicochemical and pharmacological properties.
Nascimento ALCS; Martins ICB; Spósito L; Morais-Silva G; Duarte JL; Rades T; Chorilli M
Int J Pharm; 2024 Mar; 653():123857. PubMed ID: 38281693
[TBL] [Abstract][Full Text] [Related]
4. Tabletting of solid dispersion particles consisting of indomethacin and porous silica particles.
Takeuchi H; Nagira S; Tanimura S; Yamamoto H; Kawashima Y
Chem Pharm Bull (Tokyo); 2005 May; 53(5):487-91. PubMed ID: 15863917
[TBL] [Abstract][Full Text] [Related]
5. Spray-dried amorphous solid dispersions of simvastatin, a low tg drug: in vitro and in vivo evaluations.
Ambike AA; Mahadik KR; Paradkar A
Pharm Res; 2005 Jun; 22(6):990-8. PubMed ID: 15948043
[TBL] [Abstract][Full Text] [Related]
6. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
Basavoju S; Boström D; Velaga SP
Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
[TBL] [Abstract][Full Text] [Related]
8. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
Chieng N; Aaltonen J; Saville D; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
[TBL] [Abstract][Full Text] [Related]
9. The preparation of rapidly disintegrating tablets in the mouth.
Sugimoto M; Matsubara K; Koida Y; Kobayashi M
Pharm Dev Technol; 2001 Nov; 6(4):487-93. PubMed ID: 11775950
[TBL] [Abstract][Full Text] [Related]
10. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J
Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816
[TBL] [Abstract][Full Text] [Related]
11. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone.
Fujii M; Okada H; Shibata Y; Teramachi H; Kondoh M; Watanabe Y
Int J Pharm; 2005 Apr; 293(1-2):145-53. PubMed ID: 15778052
[TBL] [Abstract][Full Text] [Related]
13. Use of glancing angle X-ray powder diffractometry to depth-profile phase transformations during dissolution of indomethacin and theophylline tablets.
Debnath S; Predecki P; Suryanarayanan R
Pharm Res; 2004 Jan; 21(1):149-59. PubMed ID: 14984270
[TBL] [Abstract][Full Text] [Related]
14. Physical stability and solubility of the thermotropic mesophase of fenoprofen calcium as pure drug and in a tablet formulation.
Patterson J; Bary A; Rades T
Int J Pharm; 2002 Oct; 247(1-2):147-57. PubMed ID: 12429493
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting the characteristics of rapidly disintegrating tablets in the mouth prepared by the crystalline transition of amorphous sucrose.
Sugimoto M; Maejima T; Narisawa S; Matsubara K; Yoshino H
Int J Pharm; 2005 May; 296(1-2):64-72. PubMed ID: 15885456
[TBL] [Abstract][Full Text] [Related]
16. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds.
Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
J Pharm Sci; 2005 Sep; 94(9):1998-2012. PubMed ID: 16052554
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-compacted and spray-congealed indomethacin/polyethyleneglycol systems.
Fini A; Rodriguez L; Cavallari C; Albertini B; Passerini N
Int J Pharm; 2002 Oct; 247(1-2):11-22. PubMed ID: 12429481
[TBL] [Abstract][Full Text] [Related]
18. The impact of diluents on the compaction, dissolution, and physical stability of amorphous solid dispersion tablets.
Yu D; Hoag SW
Int J Pharm; 2024 Apr; 654():123924. PubMed ID: 38395318
[TBL] [Abstract][Full Text] [Related]
19. Chemoinformetrical evaluation of dissolution property of indomethacin tablets by near-infrared spectroscopy.
Otsuka M; Tanabe H; Osaki K; Otsuka K; Ozaki Y
J Pharm Sci; 2007 Apr; 96(4):788-801. PubMed ID: 17238202
[TBL] [Abstract][Full Text] [Related]
20. Designing a molecular delivery system within a preclinical timeframe.
Henck JO; Byrn SR
Drug Discov Today; 2007 Mar; 12(5-6):189-99. PubMed ID: 17331883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
